BioGaia AB (publ)
BGLAF
$8.87
-$0.8517-8.76%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -35.86% | 19.88% | -62.59% | 35.67% | 5.61% |
| Total Depreciation and Amortization | 5.20% | 1.94% | 25.46% | -6.15% | -11.49% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -9.49% | -161.69% | 317.65% | 256.65% | -1,065.76% |
| Change in Net Operating Assets | 37.81% | 33.74% | 83.93% | -120.69% | -201.17% |
| Cash from Operations | -32.96% | -17.34% | 4.86% | 12.16% | -46.99% |
| Capital Expenditure | 92.45% | 100.38% | 67.31% | 91.04% | -589.54% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1,700.00% | -678.26% | 88.24% | 72.00% | 98.04% |
| Cash from Investing | 92.25% | 98.21% | 67.36% | 91.02% | -562.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 21.08% | 21.30% | -29.14% | 18.89% | 22.46% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -134.22% | -- |
| Other Financing Activities | -- | -234.77% | -- | -- | -- |
| Cash from Financing | 23.05% | 67.19% | 970.62% | -132.71% | 31.77% |
| Foreign Exchange rate Adjustments | -221.77% | 215.27% | 11.94% | -130.99% | 594.72% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -47.74% | 17.60% | 33.64% | -171.97% | -48.69% |